Serotonin Receptor Found to Drive Bone Cancer Spread and Chemotherapy Failure
Researchers report that the serotonin receptor HTR1D drives osteosarcoma metastasis and doxorubicin resistance through a c-MYC/MAPK feedback loop and CCL2/5-HT-mediated ...
